<DOC>
	<DOC>NCT01166451</DOC>
	<brief_summary>The purpose of this clinical trial was to determine if high-iron or low-iron formula, containing an average of 12.7 mg/L or 2.3 mg/L respectively, had differing effects on iron status in infancy and on development longitudinally.</brief_summary>
	<brief_title>The Anemia Control Program: High or Low Iron Supplementation</brief_title>
	<detailed_description>For a detailed description of the clinical trial setting and procedures in infancy, please refer to the following: Walter T, Pino P, Pizarro F and Lozoff B. Prevention of iron-deficiency anemia: Comparison of high- and low-iron formulas in term healthy infants after six months of life. J Pedr 1998:132:635-40.</detailed_description>
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Anemia, Iron-Deficiency</mesh_term>
	<mesh_term>Deficiency Diseases</mesh_term>
	<mesh_term>Iron</mesh_term>
	<criteria>Birth weight &gt;= 3.0 kg single birth no major congenital anomalies no major birth or neonatal complications no emergency csection no jaundice requiring phototherapy no hospitalization for more than 5 days no chronic illness no iron therapy already started to received some bottle feedings by 6 months of age residence outside identified neighborhoods another infant &lt;12 months in household infant in daycare unstable, illiterate, or psychotic caregiver</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>6 Months</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>iron deficiency anemia</keyword>
	<keyword>cognitive development</keyword>
	<keyword>motor development</keyword>
</DOC>